ABSTRACT PURPOSE: To describe our clinical experience in wavefront-guided LASIK enhancements using the WaveLight ALLEGRETTO system (WaveLight Technologie AG, Erlangen, Germany) for symptomatic eyes previously treated with standard LASIK.
METHODS:
Twenty-six eyes of 20 patients with residual myopia, hyperopia, or mixed astigmatism and/or night vision symptoms after primary standard LASIK were considered for wavefront-guided customized retreatment using the WaveLight ALLEGRETTO WAVE 200 Hz excimer laser system (model 106). Preoperative best spectaclecorrected visual acuity (BSCVA), uncorrected visual acuity, topography with the ALLEGRETTO Topolyzer, wavefront analysis using the ALLEGRETTO WAVE Tscherning Analyzer, and contrast sensitivity were compared to postoperative (enhancement) measurements.
RESULTS: Twenty-two of the original 26 eyes underwent wavefront-guided enhancement, 4 were excluded because they did not meet wavefront-guided treatment inclusion guidelines of this study. Mean follow-up was 8 months (range: 6 to 13 months). All patients were within Ϯ0.50 diopters (manifest refraction) of intended postoperative refraction. The mean preoperative BSCVA improved from 20/25 to 20/18 postoperatively. All patients gained at least one line of BSCVA, and a maximum of three lines. There was no loss of BSCVA in any patient. The total amount of high order aberrations (RMSH) decreased from an average of 1.04 to 0.46 µm. Patients also had a mean improvement in low contrast sensitivity of 59%.
CONCLUSIONS: Based on this small series, customized wavefront-guided enhancements using the WaveLight ALLEGRETTO system in patients who underwent previous LASIK appear to be safe and effective in correcting residual refractive error, reducing high order aberrations, and improving visual symptoms when reliable and reproducible measurements are achieved. [J Refract Surg. 2006;22:xxx-xxx.] S everal wavefront-guided excimer laser platforms are available today, and some have been shown to provide good results in enhancement in patients with residual problems after refractive surgery.
1,2 This study is designed to evaluate the safety and effi cacy of wavefront-guided LASIK enhancements using the ALLEGRETTO system (Wavefront analyzer and ALLEGRETTO WAVE 200Hz excimer laser; WaveLight Technologie AG, Erlangen, Germany) for symptomatic eyes after LASIK.
PATIENTS AND METHODS
Twenty-six symptomatic eyes that underwent LASIK were evaluated for possible wavefront-guided enhancement with the WaveLight ALLEGRETTO system. Inclusion criteria were previous LASIK surgery with residual myopia, hyperopia, or mixed astigmatism with a refractive error within Ϯ1.50 diopters (D) (spherical equivalent). The diameter of the planned wavefront-guided laser treatment had to be у6 mm and р7 mm. The root-mean-square higher order aberration (RMSH) value had to be у0.4 µm when measured by the ALLEGRET-TO WAVE Analyzer at a 6.5-mm pupil diameter. Indications included: 1) small original optical zone, 2) decentered ablation, 3) irregular astigmatism, 4) night vision problems, and 5) under-and overcorrection. An additional criterion for study inclusion was our ability to obtain highly reproducible, higher aberration maps that had a diameter of at least 6 mm after the eye had been dilated with a single drop of tropi-Wavefront-guided Enhancements/Kanellopoulos & Pe camide 1%. The wavefront measurements were taken in a dark room 20 to 30 minutes following the single 1% tropicamide drop administration.
Preoperative evaluation of each patient included refraction (manifest, cycloplegic, and wavefront), uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), measurement of scotopic pupil size (Colvard Pupillometer; Oasis Medical, Glendora, Calif), topography and simulated K with the Orbscan II (Bausch & Lomb, Rochester, NY), and wavefront measurements using the ALLEGRETTO WAVE Topolyzer (WaveLight Technologie).
The ALLEGRETTO WAVE Analyzer, prior to generating customized treatment information for the laser apparatus, took the average of four surgeon-selected highly reproducible maps of each patient's higher and lower order aberrations. The reproducibility of the individual wavefront measurements was determined by the surgeon both qualitatively by comparing the topographic distribution of high order aberrations as well as quantitatively by comparing total and individual RMS deviation and individual Zernike polynomials. On the fi nal treatment planned by the laser software, the surgeon could only modify the amount of sphere corrected when the clinical measurements were significantly different than the default sphere calculated by the wavefront measurements and the wavefront treatment diameter, which had to be 6, 6.5, or 7 mm, according to our study design.
The system's software does not currently allow manual changes in the amount and axis of astigmatism, because the average of the high order aberration maps predetermines this information. All cases involved lifting, but never cutting, of the original LASIK fl ap. The fl ap diameter and hinge length were measured intraoperatively. Ultrasonic pachymetry measurements were obtained preoperatively and following lifting of the fl ap, and the data were used to calculate the residual stromal bed thickness using the subtraction method.
Patient contrast sensitivity was measured pre-and postoperatively under mesopic conditions, using low contrast materials, and glare was measured preoperatively by means of the CSV-1000 (VectorVision, Arcanum, Ohio). Intraoperative complications were recorded in the patient's chart.
Patients' subjective responses to their visual function postoperatively were also recorded. On a scale of Ϫ1 to 3, Ϫ1 represented worsening, 0 represented no improvement, and 1-3 represented improvement.
Postoperative follow-up intervals were 1 day, 1 week, 1 month, 3 months, 6 months, and 1 year, at which time all of the above parameters were remeasured. At these follow-up intervals, adverse effects and/or complications were also evaluated. The measurements were performed by the surgeon (A.J.K.) and his associate optometric staff.
RESULTS
This study included 22 of the 26 eyes considered, all of whom were symptomatic with night vision problems or mesopic and scotopic ghosting. We excluded four patients: one did not possess the calculated amount of residual corneal thickness necessary for retreatment (we generally require a stromal bed reserve of at least 260 µm under the fl ap following the enhancement and a total corneal reserve of 400 µm). The three remaining patients were excluded because of our inability to obtain reproducible wavefront maps. They were all initial corrections of Ͼ7.0 D of myopia and the specifi c wavefront measurements on these eyes were found to be variable both qualitatively when evaluating topographic representation of high order aberrations as well as quantitatively when comparing specifi c RMS deviations of various Zernike polynomials.
Follow-up ranged from 6 to 13 months (mean: 8 months). Of the 22 eyes treated, the average preoperative amount of sphere was Ϫ0.92 D (range: plano to Ϫ1.50 D). The mean amount of cylinder was Ϫ0.85 D (range: 0 to Ϫ1.75 D). The mean preoperative BSCVA was 20/25, and this improved to a mean of 20/18 postoperatively. No patient lost lines of BSCVA. All patients gained at least one line of BSCVA, and a maximum of three lines. The total amount of high order aberrations, as measured by the parameter RMSH, decreased from an average of 1.04 to 0.46 µm. In addition, patients experienced a mean improvement in low contrast sensitivity of 59% (Figs 1 and 2) . No signifi cant fl ap complications were encountered with the fl ap lifting maneuvers.
Regarding quality of vision, according to the patients' subjective responses, 21 of the 22 eyes corrected had signifi cant improvement (rated 2-3) and one had mild improvement (rated 1). The mean postoperative visual function score, as rated by the patients, was ϩ2.5.
DISCUSSION
With the popularity and volume of refractive surgery, surgeons inevitably run into some problems that result in less than satisfactory vision for the patient after the procedure. Among these problems are under-or overcorrections, decentered ablations, and small optical zone ablations that may result in "ghosting" symptoms and night vision problems. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] In these cases, the refractive surgeon is left with the diffi cult task of improving these visual complaints and the possibility of offering an enhancement procedure. Modern Wavefront-guided Enhancements/Kanellopoulos & Pe wavefront capture systems and the possibility of wavefront-guided systems have enhanced the refractive surgeon's armamentarium in this regard. The strength of these systems lies in the ability to diagnose more specifi c deviations present in the patient's wavefront map and the ability to potentially improve these deviations with customized treatments. 12, 13 This is in contrast to traditional forms of refractive correction (spectacles and "standard" ablations), which basically treat only the spherocylindrical error. This may well be the best route to take in managing patients with symptoms after LASIK given the knowledge that the previous refractive procedure may have interfered with wavefront norms and the complex nature of the refractive error.
Regarding the quality of vision in the present study, which was measured by the patients' subjective responses, the majority reported signifi cant improvement.
Wavefront measurements and our measurements of these patients' low contrast sensitivity indicated a signifi cant clinical improvement in all eyes, justifying the above subjective responses. No patient demonstrated a need for further enhancement during the study's brief follow-up period. Although the size of the study was limited, these results suggest that wavefront-guided LASIK retreatments with this laser are safe and effective for the correction of residual refractive error. We attribute the enhancement of visual function to the signifi cant improvement of the patients' high order aberrations and low contrast sensitivity. The ALLEGRETTO WAVE wavefront analyzer and excimer laser allowed us to measure and treat most symptomatic patients, with predictable outcomes.
This treatment, however, cannot be offered to all post LASIK symptomatic eyes, as several limitations are present. These limitations, as noted in our study design, are the actual objective measurements of such a deviation from normal. This means that although the patients are symptomatic, the clinical device could not measure signifi cant high order aberrations and/or deviation from low contrast sensitivity and because the clinical indices could not be altered, the treatment could not be offered.
Another limitation is obtaining several reproducible wavefront maps to maintain a high index of certainty that these results are reproducible. The specifi c wavefront technology in this study uses the Tscherning principle of calculating wavefront deviations from the image of a series of simultaneously projected laser spots onto the retina. Invariably, eyes that had undergone LASIK for spherical equivalents Ͼ7.0 D of myopia did not offer a well-defi ned image of these diagnostic laser spots and therefore the wavefront calculation on part of this technology was variable both qualitatively (site and specifi c Zernike polynomial deviation) as well as quantitatively (amount of specifi c Zernike polynomial deviation). Therefore, as noted in the study, a certain Wavefront-guided Enhancements/Kanellopoulos & Pe percentage of patients did fulfi ll our inclusion criteria, but we were not able to attain reproducible measurements and they were excluded from the study. This group of cases may be better addressed with the use of topography-guided enhancements as reported by the authors previously. 14 In this group of patients, visual rehabilitation remains problematic. Further studies and a better understanding of this technology and how it alters the physiology of vision may help better manage these patients. In addition, recent data from Applegate et al 12 indicate that actual human vision may improve with the modulation of certain Zernike modes, and not necessarily all modes as defi ned by the RMSH value. Therefore, in a theoretical setting, where we can manipulate specifi c Zernike polynomials in our wavefront-guided treatments, a more effective improvement in functional human visual acuity could result. We did not study the specifi c correction of each Zernike polynomial in these wavefront-guided enhancements, but the total high order deviation through the value of RMSH was evaluated. One may theorize that applying wavefront-guided treatments as an initial treatment may provide better results. The problem with this approach is that most wavefront aberrations were induced by surgery and are not present preoperatively. The major wavefront index change appears to be the fl ap creation process. We concentrated on using the initial fl ap to avoid further changes, theorizing that re-lifting the initial LASIK fl ap would not induce any additional high order aberration changes. Again, this is an area where further studies, preferably controlled randomized studies, could offer a more conclusive approach. 
